What HIV Vaccine Preparedness Teaches us about COVID Vaccine Distribution

I recently found a 1995 presentation with findings from my doctoral dissertation that are highly pertinent to COVID Vaccine trials. The study included anonymized interviews and surveys with the first high risk (#vulnerable) HIV vaccine efficacy trial participants. No space here to share the results but I thought readers would find the questions of interest:–Motivations for joining the trial (altruism,…